CME · Cme Group Inc.
2 customers — 25% of revenue (first six months of 2026)
“The two largest resellers of our market data represented approximately 25% of our market data and information services revenue in the first six months of 2026.”
One customer — 10% of revenue (first six months of 2026)
“One individual firm represented at least 10% of our clearing and transaction fees in the first six months of 2026.”
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Net Income non-GAAP | $2.3B | Six Months Ended June 30, 2026 | — |
| Adjusted Operating Income non-GAAP | $2.55B | Six Months Ended June 30, 2026 | — |
| Agricultural commodities ADV | 2.08M | 2Q 2026 | — |
| Agricultural commodities RPC | $1.43 | 2Q 2026 | — |
| CME Globex ADV | 27.94M | 2Q 2026 | — |
| CME Group ADV | 29.8M | Q2 2026 | — |
| Daily margin efficiencies | 95B | Q2 2026 | — |
| Energy ADV | 2.67M | 2Q 2026 | — |
| Energy RPC | $1.13 | 2Q 2026 | — |
| Equity indexes ADV | 8.63M | 2Q 2026 | — |
| Equity indexes RPC | $0.61 | 2Q 2026 | — |
| Foreign exchange ADV | 989K | 2Q 2026 | — |
| Foreign exchange RPC | $0.81 | 2Q 2026 | — |
| Interest rates ADV | 14.53M | 2Q 2026 | — |
| Interest rates RPC | $0.48 | 2Q 2026 | — |
| Metals ADV | 941K | 2Q 2026 | — |
| Metals RPC | $1.32 | 2Q 2026 | — |
| Non-U.S. ADV | 9.1M | Q2 2026 | — |
|
|
|||
| Open outcry ADV | 830K | 2Q 2026 | — |
| Privately negotiated ADV | 1.08M | 2Q 2026 | — |
| Total average rate per contract | $0.68 | Q2 2026 | — |
| Total CME Group ADV | 29.84M | 2Q 2026 | — |
| Trading Days | 62 | 2Q 2026 | — |
| average daily volume | 36.2M | Q1 2026 | — |
| average rate per contract | $0.71 | fourth-quarter 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CME
this stock
Cme Group Inc.
|
$97.33B | -2.2% | +6.4% | 23.0 | 1.7% |
|
SPGI
S&P Global Inc.
|
$124.70B | — | +7.1% | 26.7 | 2.8% |
|
ICE
Intercontinental Exchange, Inc.
|
$88.27B | -3.6% | -2.1% | 22.2 | 1.4% |
|
MCO
Moodys Corp /De/
|
$82.65B | -4.9% | +16.6% | 30.3 | 1.8% |
|
LSEGY
London Stock Exchange Group plc
|
$55.15B | -6.2% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CME | +1.8% | +7.1% | -15.7% | -0.3% | -2.3% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +2.2% | +4.5% | -26.4% | -3.1% | -14.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.